Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

McGill University

$7,500.00

Support for 2nd International Basic Science and Clinical Conference on Christianson Syndrome

EF 2016-17

Résumé
Neurodevelopmental disorders affect 1-2% of the world population and are a major cause of morbidity and societal costs. Christianson syndrome (CS) is a rare but increasing diagnosed X chromosome-linked developmental brain disorder identified in families in Canada, USA and Europe, and has relevance to a wide array of more common developmental and degenerative disorders of the brain. In spite of its increasing prevalence, Christianson syndrome has received little attention outside of a few clinics and research labs. All affected males exhibit severe intellectual disability, ataxia, epilepsy, mutism, microcephaly, neuronal degeneration and, in some cases, autistic behaviour. By comparison, female carriers of CS appear largely asymptomatic, though they have yet to been examined more closely. CS is caused by deleterious mutations in the gene SLC9A6 that was first identified and cloned by Orlowski et al in 1998. This protein regulates the pH of intracellular membrane vesicles called 'recycling endosomes' that play important roles in the targeted delivery of growth factor and neurotransmitter receptors to neuronal excitatory synapses. The meeting supported by this proposal will be the second conference on CS that will be held at McGill University in 2017 and will bring together all stake holders in understanding this disease, from clinicians and researchers to the families and individuals affected by this disorder. Key outcomes expected from this meeting include: (i) networking of the CS research and clinical community, including the introduction of junior scientists and clinicians to the importance of studying CS; (ii) generation of new ideas on the pathogenesis and possible treatment of CS and other related rare diseases; and (iii) expansion of the international CS research and clinical network to foster fully collaborative, multi-laboratory basic research and to encourage patient registry and natural history study in order to advance patient care and treatment.
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
365668
Name
Orlowski John
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Planning and Dissemination - Institute of Genetics
Projecttitle
Support for 2nd International Basic Science and Clinical Conference on Christianson Syndrome
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$7,500
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Alkali Cation/Proton Exchangers; Christianson Syndrome; Epilepsy; Genetic Mutations; Neurodegeneration; Neurodevelopment; Recycling Endosomes; Slc9a6; X-Linked Intellectual Disability
Abstract
Neurodevelopmental disorders affect 1-2% of the world population and are a major cause of morbidity and societal costs. Christianson syndrome (CS) is a rare but increasing diagnosed X chromosome-linked developmental brain disorder identified in families in Canada, USA and Europe, and has relevance to a wide array of more common developmental and degenerative disorders of the brain. In spite of its increasing prevalence, Christianson syndrome has received little attention outside of a few clinics and research labs. All affected males exhibit severe intellectual disability, ataxia, epilepsy, mutism, microcephaly, neuronal degeneration and, in some cases, autistic behaviour. By comparison, female carriers of CS appear largely asymptomatic, though they have yet to been examined more closely. CS is caused by deleterious mutations in the gene SLC9A6 that was first identified and cloned by Orlowski et al in 1998. This protein regulates the pH of intracellular membrane vesicles called 'recycling endosomes' that play important roles in the targeted delivery of growth factor and neurotransmitter receptors to neuronal excitatory synapses. The meeting supported by this proposal will be the second conference on CS that will be held at McGill University in 2017 and will bring together all stake holders in understanding this disease, from clinicians and researchers to the families and individuals affected by this disorder. Key outcomes expected from this meeting include: (i) networking of the CS research and clinical community, including the introduction of junior scientists and clinicians to the importance of studying CS; (ii) generation of new ideas on the pathogenesis and possible treatment of CS and other related rare diseases; and (iii) expansion of the international CS research and clinical network to foster fully collaborative, multi-laboratory basic research and to encourage patient registry and natural history study in order to advance patient care and treatment.
Competitiondate
201702
Approvedterm2
1 yr 0 mth
Pinamesdelim
Orlowski, John
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Genetics~ $7,500~ $0~